|
LYSMD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.34490000037025E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.24329999999329E-05 |
| Normal-vs-Stage2 |
9.683800E-03 |
| Normal-vs-Stage3 |
6.44039999999624E-05 |
| Normal-vs-Stage4 |
9.263000E-03 |
| Stage1-vs-Stage2 |
1.998400E-01 |
| Stage1-vs-Stage3 |
8.621200E-01 |
| Stage1-vs-Stage4 |
2.082800E-01 |
| Stage2-vs-Stage3 |
3.311400E-01 |
| Stage2-vs-Stage4 |
9.758800E-01 |
| Stage3-vs-Stage4 |
3.473600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.24529999978584E-07 |
| Normal-vs-AfricanAmerican |
9.817600E-01 |
| Normal-vs-Asian |
6.35319999999773E-05 |
| Caucasian-vs-AfricanAmerican |
2.036200E-04 |
| Caucasian-vs-Asian |
9.204600E-01 |
| AfricanAmerican-vs-Asian |
4.039800E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.431200E-04 |
| Normal-vs-Female |
2.41769999999031E-05 |
| Male-vs-Female |
2.440000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.80463999999159E-05 |
| Normal-vs-Age(41-60Yrs) |
4.91520000001078E-06 |
| Normal-vs-Age(61-80Yrs) |
1.658260E-02 |
| Normal-vs-Age(81-100Yrs) |
3.159600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.628600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.409710E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.620810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.204200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.618450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.720300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.440100E-02 |
| Classical-VS-Follicular |
5.298100E-02 |
| Classical-VS-Other |
8.407000E-01 |
| Classical-VS-Normal |
7.57500000000411E-05 |
| Tall-VS-Follicular |
1.364580E-03 |
| Tall-VS-Other |
2.018600E-01 |
| Tall-VS-Normal |
8.33660000032488E-07 |
| Follicular-VS-Other |
6.941000E-01 |
| Follicular-VS-Normal |
1.326090E-02 |
| Other-VS-Normal |
1.451410E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.1179999999974E-05 |
| Normal-vs-N1 |
1.86222999999375E-05 |
| N0-vs-N1 |
7.979700E-02 |
|
|
